Stockreport

MannKind rises as FDA advances rare lung disease therapy to Phase 3 trial [Seeking Alpha]

MannKind Corporation  (MNKD) 
Last mannkind corporation earnings: 2/25 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.mannkindcorp.com/press-releases
PDF The U.S. Food and Drug Administration (FDA) cleared MannKind's ( MNKD ) investigational new drug application for MNKD-101, enabling the initiation of a Phase 3 study. [Read more]